COMMUNIQUÉS West-GlobeNewswire

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference
28/05/2025
SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization [...]
Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
28/05/2025
Experienced medical device executive with deep expertise in implantable technologies joins Glucotrack as Company advances development of long-term implantable blood glucose monitoring technology RUTHERFORD, N.J., May 28 [...]
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
28/05/2025
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold Resumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M milestone due in six [...]
Vittoria Biotherapeutics to Share Trials-in-Progress Presentation from Phase 1 Study of VIPER-101 at ASCO 2025 Annual Meeting
28/05/2025
Trial is evaluating VIPER-101, a novel, gene edited, autologous dual-population CAR-T therapy in patients with T-cell lymphoma PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Vittoria Biotherapeutics Inc., a clinical- [...]
iTeos Therapeutics Announces Its Intention to Wind Down Operations
28/05/2025
- Board of Directors intends to cease operations - Company to focus efforts on selecting best path to deliver near-term value to shareholders - Exploring potential asset sales including EOS-984, EOS-215, and a [...]
Alpha Tau to Present at Jefferies Global Healthcare Conference
28/05/2025
JERUSALEM, May 28, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced [...]
HCVC leads kyron.bio €5.5M round to use glycan engineering for advanced drug design
28/05/2025
The company has developed the first-ever platform to unlock precision control over glycans, essential sugar molecules found on the surface of a therapeutic. This innovation paves the way for safer, more potent [...]
Flare Therapeutics to Participate in Jefferies Global Healthcare Conference
28/05/2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other [...]
Immunotherapeutic Targets for Recurrent Medulloblastoma Receives $85K Grant from Brain Cancer Canada
28/05/2025
TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- Brain Cancer Canada is proud to award $85,000 to a groundbreaking research project led by Dr. Sheila Singh and her team at McMaster University. The project titled "Lamin B [...]
Olympia Pharmaceuticals Secures $637,000 Workforce Training Grant to Boost Job Creation in Orlando
28/05/2025
The funding will train 100 new employees at Wesley Pharmaceuticals, supporting local talent and healthcare innovation in Orlando ORLANDO, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , a leading [...]
Marius Pharmaceuticals Receives Sixth U.S. Patent Allowance for KYZATREX® (testosterone undecanoate) CIII Capsules Extending Coverage to 2040
28/05/2025
RALEIGH, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals , a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, announced today that the United States Patent and [...]
DEBRA Research and Dermaliq Enter into a Strategic Collaboration to Advance Cutaneous Drug Delivery for Epidermolysis Bullosa
28/05/2025
Initial programs will focus on developing innovative topical treatments and drug therapies for wound healing and itch relief, plus prophylactic therapies for people with Epidermolysis Bullosa. Dermaliq’s proprietary [...]
Besample Raises $1.1M to Take Behavioral Science Beyond the West
28/05/2025
Led by Gutter Capital, the pre-seed round supports a new platform that tackles Western data bias in behavioral science and AI NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Besample , a platform enabling researchers to [...]
Trading in GN Store Nord shares by board members, executives and associated persons
28/05/2025
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN [...]
Shareholders vote in favor of all proposals by the Board at Idorsia’s Annual General Meeting 2025
28/05/2025
Allschwil, Switzerland – May 28, 2025 At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted convincingly in favor of all proposals by the Board of Directors. [...]
SBC Medical Announces Attendance at Upcoming Investor Events
28/05/2025
IRVINE, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global franchise and provider of services for aesthetic clinics, today announced [...]
InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum
28/05/2025
JENA, Germany, May 28, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Independent [...]
Pharming Group to participate in June investor conferences
28/05/2025
Leiden, the Netherlands, May 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month [...]
NANOBIOTIX participera à la conférence investisseurs annuelle Jefferies Global Healthcare
28/05/2025
PARIS et CAMBRIDGE, Mass., 28 mai 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société » ), société française de biotechnologie en phase de développement clinique avancé, pionnière des [...]

Pages